Moderna says its COVID-19 vaccine is effective in teenagers
The company will seek FDA approval next month.
Moderna seeks to expand the use of its vaccine.
Moderna's coronavirus vaccine is effective in 12- to 17-year-olds, the company said Tuesday. The pharmaceuticals maker will apply to the US Food and Drug Administration in June for approval to administer its vaccine to teenagers.
The Pfizer vaccine has already been approved for use in teenagers.
More than 121 million doses of Moderna's vaccine had been administered in the US as of Monday, according to data from the Centers for Disease Control and Prevention, and nearly 53 million people have been fully vaccinated with it.
See also: COVID-19 vaccine side effects: What's normal and what to look out for
Other Wellness Guides
Personal Care
Sleep
Fitness
Nutrition
Medical and Mental Health